BIOLASE Appoints Michael DiTolla, DDS, FAGD To Its Board Of Directors
on November 15, 2019 at 11:30 am
IRVINE, Calif., Nov. 15, 2019 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, today announced it appointed Michael DiTolla, DDS, FAGD to its board of directors, effective November 14, 2019. The appointment increases the size of the BIOLASE Board of Directors to seven members. Dr. DiTolla, age 55, is a seasoned dental executive and a graduate of the University of the Pacific School of Dentistry.
Edited Transcript of BIOL earnings conference call or presentation 6-Nov-19 9:30pm GMT
on November 7, 2019 at 10:37 pm
Q3 2019 BIOLASE Inc Earnings Call
BIOLASE Reports Third Quarter 2019 Results
on November 6, 2019 at 9:05 pm
- Third Quarter Net Revenue of $8.6 Million - Company Continues to Drive Down Expenses as it Expects to Achieve Adjusted EBITDA break-even in the 2019 Fourth Quarter - Conference Call Today at 4:30pm ET ...
BIOLASE Secures $3 Million Revolving Line Of Credit
on October 31, 2019 at 9:00 pm
IRVINE, Calif., Oct. 31, 2019 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, today announced that it has secured a $3 million revolving line of credit from Pacific Mercantile Bank ("the Bank"), the wholly owned subsidiary of Pacific Mercantile Bancorp. Funds from the two-year accounts receivable line of credit will be used for working capital purposes.
BIOLASE Announces Pricing of $8.5 Million Public Offering of Common Stock and Concurrent Private Placement of Convertible Preferred Stock
on October 25, 2019 at 1:35 am
The Benchmark Company, LLC and Dougherty & Company LLC are acting underwriters for the common stock offering. BIOLASE also announced that investors affiliated with Jack W. Schuler and Oracle Investment Management, Inc. have agreed to purchase 69,565 unregistered shares of the Company's convertible preferred stock at a price of $57.50 per share in a concurrent private placement.
BIOLASE Wraps Inaugural Advancing Dentistry Symposium
on October 23, 2019 at 1:00 pm
More Than 250 Dental Professionals Attended The Event To Learn The Latest Trends And Innovations In Dentistry From Leading Industry Experts IRVINE, Calif. , Oct. 23, 2019 /PRNewswire/ -- BIOLASE, Inc. ...
BIOLASE Announces Select Preliminary Third Quarter 2019 Financial Results And Date For Reporting Third Quarter 2019 Results
on October 21, 2019 at 11:00 am
IRVINE, Calif. , Oct. 21, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced select unaudited preliminary financial results for the third quarter ended ...
BIOLASE Announces First-Ever U.S. & Canada Regulatory Clearance of Laser Crown and Veneer Removal
on October 15, 2019 at 1:00 pm
IRVINE, Calif., Oct. 15, 2019 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, is proud to announce that Waterlase dental lasers received U.S. and Canada regulatory clearance for crown and veneer removal. This new indication allows dentists to remove crowns and veneers in less than five minutes using laser technology. BIOLASE is the only dental laser company with this clearance.
BIOLASE to Participate at Dougherty & Company Institutional Investor Conference on September 5, 2019
on August 28, 2019 at 11:30 am
IRVINE, Calif. , Aug. 28, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate at the 4 th Annual Dougherty & Company ...
Edited Transcript of BIOL earnings conference call or presentation 8-Aug-19 8:30pm GMT
on August 19, 2019 at 2:28 am
Q2 2019 BIOLASE Inc Earnings Call